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https://doi.org/10.1016/j.stemcr.2018.05.014SUMMARYBone, cartilage, and marrow adipocytes are generated by skeletal progenitors, but the relationships between lineages and mechanisms
controlling their differentiation are poorly understood. We established mouse clonal skeletal progenitors with distinct differentiation
properties and analyzed their transcriptome. Unipotent osteogenic and adipogenic cells expressed specific transcriptional programs,
whereas bipotent clones combined expression of those genes and did not show a unique signature.We tested potential regulators of line-
age commitment and found that in the presence of interferon-g (IFNg) adipogenic clones can be induced to osteogenesis and that their
adipogenic capacity is inhibited. Analysis of IFNg-regulated genes showed that lineage signatures and fate commitment of skeletal pro-
genitors were controlled by EGR1 and EGR2. Knockdown experiments revealed that EGR1 is a positive regulator of the adipogenic tran-
scriptional program and differentiation capacity, whereas EGR2 inhibits the osteogenic program and potency. Therefore, our work
revealed transcriptional signatures of osteogenic and adipogenic lineages and mechanism triggering cell fate.INTRODUCTION
Most somatic cells are replenished during life through dif-
ferentiation of adult stem cells. It is suggested that differen-
tiated cells of skeletal tissues, such as osteoblasts, marrow
adipocytes, and chondrocytes, originate from putative
skeletal stem cells, also referred to as mesenchymal stem
cells, residing in bone marrow stroma (Bianco and Robey,
2000; Caplan, 1991; Owen and Friedenstein, 1988). Clas-
sical experiments on serial ectopic transplantations of
bone marrow showed the existence of self-renewing skel-
etal stem cells, which can recapitulate formation of bone
ossicle with hematopoiesis-supportive stroma (Frieden-
stein et al., 1968; Sacchetti et al., 2007; Tavassoli and
Crosby, 1968). Nevertheless, which cell lineages can be
generated from bone marrow skeletal stem cells and how
their differentiation is controlled still remains unclear. Ge-
netic fate mapping studies using Grem1-CreERT (Worthley
et al., 2015), LepR-Cre (Zhou et al., 2014), and Mx1-Cre
(Park et al., 2012) revealed distinct subsets of cells contrib-
uting to skeletal tissues, and notably each strategy resulted
in labeling different cell types. This suggests that skeletal
tissues may be generated by multiple subsets of stem and
progenitor cells with distinct developmental potential,
whichmay function in different locations and at particular
stages of development (Kassem and Bianco, 2015).
Heterogeneity within the population of bone marrow
skeletal progenitors may also be reflected by cells cultured
in vitro. Multiple studies revealed that single-cell-derived212 Stem Cell Reports j Vol. 11 j 212–227 j July 10, 2018 j ª 2018 The Auth
This is an open access article under the CC BY-NC-ND license (http://creativstrains of bone marrow stromal cells (BMSCs) are heteroge-
neous in their differentiation potential using in vitro tests
(Banfi et al., 2000; Muraglia et al., 2000; Okamoto et al.,
2002; Russell et al., 2010; Sarugaser et al., 2009; Zhou
et al., 2014) and transplantation assays (Gronthos et al.,
2003; Kuznetsov et al., 1997; Sacchetti et al., 2007; Sworder
et al., 2015).
Several factors have been proposed to regulate lineage de-
cisions of skeletal progenitors, among them canonicalWnt
(wingless-type MMTV integration site family) (Boyden
et al., 2002; Cui et al., 2011; Gong et al., 2001), VEGF
(vascular endothelial growth factor) (Chan et al., 2015),
RUNX2 (runt-related transcription factor 2), and PPARg
(peroxisome proliferator-activated receptor g) (Komori
et al., 1997; Tontonoz et al., 1994; Hong et al., 2005; Nish-
ikawa et al., 2010). In fact, most of the pathways identified
so far positively regulate differentiation of BMSCs into one
lineage and inhibit the other, but this does not provide
enough evidence that these factors actually determine
cell fate decisions in a multipotent progenitor cell and
not just play a role downstream during differentiation;
hence, the key events in BMSC lineage commitment are
still to be identified.
In this work, we specified different types of cultured skel-
etal progenitors within a BMSC population using in vitro
and in vivo differentiation assays. Systematic expression
profiling of clonally derived skeletal progenitors revealed
transcriptional signatures for osteogenic and adipogenic
lineages. Furthermore, we found that levels of transcriptionor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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factors EGR1 and EGR2 are critical for lineage-specific
expression and commitment of progenitors to osteo- and
adipogenic fates.RESULTS
Establishment of Clonal Skeletal Progenitors with
Distinct Differentiation Properties
The main obstacles to in vitro studies of primary BMSCs are
their limited proliferation and loss of differentiation capac-
ity during passaging (Digirolamo et al., 1999; Muraglia
et al., 2000; Sarugaser et al., 2009). We took advantage of
irtTA-GBD*-TAg transgenic mice previously established in
our group (Anastassiadis et al., 2010; Rostovskaya and
Anastassiadis, 2012), which harbor a system for inducible
expression of SV40 large T antigen, and thus can be used
for isolation and conditional immortalization of somatic
cells (Figures S1A and S1B). BMSCs isolated from the trans-
genic mice continuously proliferated upon induction of
large T antigen by two ligands, dexamethasone and doxy-
cycline (Dex/Dox). Large T antigen was deinduced 3 days
after withdrawal of Dex/Dox, and concomitantly the cells
ceased proliferation (Anastassiadis et al., 2010). All experi-
ments in our study were performed at least 3 days after
removal of Dex/Dox unless otherwise stated, to exclude in-
fluence of these ligands and large T antigen expression.
We confirmed that conditionally immortalized BMSCs
maintained the potential to differentiate into osteogenic,
adipogenic, and chondrogenic lineages in vitro (Figure 1A),
which was not altered after long-term passaging (Figures
S1C and S1D). Nevertheless, the stringent criterion
defining skeletal progenitors is their ability to generate
bone at heterotopic sites in an in vivo transplantation assay
(Bianco and Robey, 2015; Bianco et al., 2008). To test this,
we expanded two cell lines derived from individual mice
for 8 passages and transplanted subcutaneously into
SCID/beige mice in conjunction with a hydroxyapatite/
tricalcium phosphate (HA/TCP) ceramic carrier. After
8 weeks, both transplanted BMSC lines established ossicles
(4/4 and 3/4, Figure 1B). These data confirm that we
established mouse BMSCs containing bona fide skeletalFigure 1. Characterization of Mouse BMSC Lines and Clonally Der
(A) In vitro differentiation potential of BMSCs derived from whole bon
chondrocytes (inset shows magnified region with characteristic lacun
(B) Formation of heterotopic bone in transplants derived from con
transplant and higher magnification; Sirius red and H&E.
(C) Establishment of clonally derived skeletal progenitors and screen
(D) Transplantation assay of clonally derived skeletal progenitors; Si
plantations of cell lines and clones from 2 individual mice (4 transpl
Error bars indicate standard deviations (SDs). For sections of transpla
double arrow, osteoblast. See also Figure S1.
214 Stem Cell Reports j Vol. 11 j 212–227 j July 10, 2018progenitors, which can be expanded in vitro using condi-
tional immortalizationwhilemaintaining their differentia-
tion properties.
To explore the heterogeneity of BMSCs, we subjected
conditionally immortalized BMSC lines to cellular cloning
and then tested the clones for their differentiation capacity
in vitro and in vivo. Using in vitro differentiation protocols,
the clones were examined for their ability to produce
mature osteo-, adipo-, and chondrogenic cells, ‘‘O’’, ‘‘A’’
and ‘‘C’’ respectively (Figure 1C). We identified tripotent
clones (‘‘OAC’’), as well as clones capable of generating
two lineages in all possible combinations (‘‘OA’’, ‘‘OC’’
and ‘‘AC’’) and unipotent clones (‘‘O’’, ‘‘A’’ and ‘‘C’’). To
confirm homogeneity of the established single-cell-derived
clones, we performed the second round of cellular cloning
and the resulting subclones were checked for osteogenic
and adipogenic differentiation (Figure S1E). The chondro-
genic assay was not tested in this experiment. Most
subclones generated from the bipotent ‘‘OA’’ cells (78%–
94%) inherited properties of the parental clones, indicating
that these were homogeneous populations of cells capable
of both types of differentiation and did not represent a
mixture of unipotent cells. Also, 68%–96% of subclones
derived from the ‘‘O’’ and ‘‘A’’ progenitors reproduced those
potentials. These results suggested that clonally derived
subpopulations of BMSCs relatively stably maintained
their properties during culturing.
To test whether different types of progenitors pre-existed
in the bone marrow and were not just a consequence of
in vitro expansion, we isolated clonal cell populations
from primary bone marrow colony-forming units—fibro-
blasts (CFU-Fs) by plating at low density, then immortal-
ized and checked for osteo- and adipogenic potential
(Figure S1F). Among the clones initiated by CFU-Fs estab-
lished from five mice, bipotent ‘‘OA’’ and unipotent ‘‘O’’
and ‘‘A’’ cells were identified (29.6%, 63.0%, and 7.4%,
respectively), confirming heterogeneity of skeletal progen-
itors in mice.
We tested osteogenic properties of chosen clonal skeletal
progenitors further using a transplantation assay on HA/
TCP carrier into immunocompromised mice. This method
represents a rigorous assay for the osteogenic capacity ofived Populations of Skeletal Progenitors
e marrow of irtTA-GBD*-TAg transgenic mice to osteo-, adipo-, and
ar structure of cartilage).
ditionally immortalized BMSC lines. Sections through the whole
ing of their differentiation properties.
rius red staining of sections. Right panel: quantification of trans-
ants from each).
nts: b, bone; ft, fibrous tissue; c, HA/TCP carrier; arrow, osteocyte;
cells, withmuch lower frequency of adipocyte formation in
the transplants (Kuznetsov et al., 1997; Sacchetti et al.,
2007, 2016). Chondrogenic differentiation of postnatal
skeletal progenitors is rarely observed in this test; therefore,
we chose clones based on their osteogenic and adipogenic
properties, independent of their chondrogenic capacity
in vitro, and transplanted ‘‘OAC’’, ‘‘OC’’ and ‘‘A’’ clones
derived from two mice. After 8 weeks, ‘‘OAC’’ and ‘‘A’’ cells
produced grafts consisting of fibrotic tissue, and only ‘‘OC’’
clones formed bone, albeit with a lower efficiency than the
parental line (Figure 1D). We also confirmed that the trans-
plants contain donor cells by PCR genotyping using
primers for irtTA and T antigen transgenes that marked
the transplanted cells but not the host. Despite the fact
that not all types of progenitors were tested, these data
may indicate that the clones that possess osteogenic but
not adipogenic capacity in vitro (such as ‘‘OC’’ and ‘‘O’’)
can form bone in vivo and represent bona fide osteogenic
progenitors. On the other hand, the cells capable of both
osteo- and adipogenic differentiation in vitro (such as
‘‘OAC’’ and ‘‘OA’’) do not reveal the ability to generate
bone in vivo, which is an apparent inconsistency between
the two tests. Nevertheless, we maintained the names of
the clones according to their in vitro potency, bearing in
mind their in vivo potential. We further emphasize that
our transplantation assay is not indicative for adipogenesis
and chondrogenesis in vivo.
Expression Profiling of Clonally Derived Skeletal
Progenitors
To characterize skeletal progenitors with distinct lineage
commitment, we performed sequencing-based expression
profiling (RNA sequencing [RNA-seq]) of the clonal popu-
lations. We used the following progenitor types according
to their in vitro differentiation potential: ‘‘OAC’’, ‘‘OA’’,
‘‘OC’’, ‘‘AC’’, ‘‘O’’ and ‘‘A’’; ‘‘C’’ cells were not analyzed
due to the rarity of these clones (Figure S2A). We compared
transcription profiles of the analyzed populations, but
strikingly we could not identify genes exclusively ex-
pressed in each of the six cell types. Clustering analysis
(Figure 2A) showed a strong resemblance between ‘‘OAC’’
and ‘‘OA’’ clones (25 differentially expressed genes
[DEGs]), as well as ‘‘OC’’ and ‘‘O’’ (46 DEGs). ‘‘AC’’ and
‘‘A’’ also clustered together despite a higher number of
DEGs (124 genes). This result showed that chondrogenic
capacity did not largely affect transcriptome profile of
the cells, at least in our system. Moreover, we suggest
that different cell types did not show unique expression
patterns because the clones were highly similar within
the clusters. Therefore, we checked differential gene
expression between three clusters: ‘‘O’’ (O + OC), ‘‘OA’’
(OA + OAC), and ‘‘A’’ (A + AC) (Figure 2B). We found
180 genes with higher expression in the ‘‘O’’ group and186 genes in the ‘‘A’’ group; however, we could not iden-
tify specific genes for the cells with both potentials. Never-
theless, the ‘‘OA’’ group shared the expression of 102 upre-
gulated genes with the ‘‘O’’ group and 62 genes with the
‘‘A’’ group. These data suggest that the clones that are bipo-
tent in vitro, partially co-express osteogenic and adipogenic
genes, and do not have unique identity. Therefore, we
considered only the cells of ‘‘O’’ and ‘‘A’’ clusters for
further experiments in our study.
We termed the set of genes upregulated in the ‘‘O’’ group
compared with the ‘‘A’’ group as an ‘‘osteogenic signature’’
(282 genes) and the converse dataset as an ‘‘adipogenic
signature’’ (248 genes). Functional annotation revealed
that both osteogenic and adipogenic signatures were en-
riched for the genes involved in bone and skeletal system
development, ossification, and development (Figure 2C),
indicating a functional and developmental relationship be-
tween the two types of progenitors.
The transcriptional signatures that we described con-
tained genes involved in osteo- and adipogenesis (such as
Sp7 [Osterix], Dlx3, Dlx5 within the osteogenic, Pparg and
Cebpawithin the adipogenic signature), among others (Fig-
ure 2D). We verified expression of selected DEGs in inde-
pendent clones (Figure S2B), and confirmed differential
expression in 88% of the cases (21/24 genes). On a special
note, Runx2 was expressed highly across all clones and was
not among DEGs.
We tested expression of several proteins in the clones us-
ing immunostaining (Figures 3A and 3B) and western blot
(Figure 3C). We observed high expression of SP7 in the ‘‘O’’
clones compared with ‘‘A’’, whereas the latter expressed
higher PPARg, C/EBPa, EGR2, and STAT1, in concordance
with the expression profiling results. ‘‘OA’’ cells generally
showed intermediate levels of expression of those markers
between ‘‘O’’ and ‘‘A’’ cell types. Additionally, using co-
staining with antibodies for SP7 and PPARg, we observed
that bipotent ‘‘OA’’ clones co-expressed osteogenic and adi-
pogenic genes at the single-cell level (Figure 3A), and thus
do not represent a mixture of cells with heterogeneous
expression of osteo- or adipogenic signatures.
Signaling Pathways in Lineage Commitment of
Skeletal Progenitors
To find potential regulators of osteo- and adipogenic fates
of skeletal progenitors, we analyzed representative mem-
bers of signaling pathways in the osteogenic and adipo-
genic transcriptional signatures derived from our RNA-seq
analysis (Figure 4A). Osteogenic cells expressed members
of canonical and non-canonical Wnt, Hedgehog (SHH),
parathyroid hormone (PTH), and bone morphogenetic
protein (BMP) pathways, whereas adipogenic cells pro-
duced antagonists for Wnt and BMP and had upregu-
lated targets of interferon-g (IFNg). To test their role inStem Cell Reports j Vol. 11 j 212–227 j July 10, 2018 215
Figure 2. Gene Expression Analysis of Clonally Derived Skeletal Progenitors with Distinct Differentiation Potential
(A) RNA profiling of clonally derived skeletal progenitors. The distances between cell types were calculated as numbers of differentially
expressed genes (DEGs) at p < 0.01, as shown on the heatmap in (B). Darker blue corresponds to higher similarity between the clones.
(B) Heatmap representing DEGs in the clusters of clones with osteogenic, adipogenic, and both potentials. Cells with both properties (OA:
OAC + OA) co-expressed genes of osteo- (O: OC + O) and adipogenic (A: AC + A) cells and did not express unique genes.
(C) Enrichment of gene ontology (GO) terms in osteogenic and adipogenic signatures of skeletal progenitors.
(D) Representative genes of osteogenic and adipogenic signatures. Box plots show DEseq normalized expression values.
In the box plots, the horizontal line indicates the median, and the box shows the 25th and 75th percentiles. See also Figure S2.differentiation, we treated mouse conditionally immortal-
ized clonal progenitors with the osteogenic or adipogenic
medium with or without corresponding ligands (Figures
4B and 4C), including WNT3a, WNT5a, SHH, PTHrP,
BMP-2, and IFNg. The properties of ‘‘O’’ clones were not
altered in all the aforementioned experimental conditions.
However, activation of those pathways in the ‘‘A’’ cells
affected their differentiation capacity. In the presence of
WNT3a, WNT5a, and IFNg, the cells demonstrated exten-
sive mineralization in osteogenic conditions in vitro.
A mild osteogenic effect was also observed after treatment
with SHH, PTHrP, and BMP-2. In addition, WNT3a and
IFNg prevented adipogenic differentiation, whereas the
other ligands did not. Adipogenesis was also inhibited in216 Stem Cell Reports j Vol. 11 j 212–227 j July 10, 2018‘‘OA’’ progenitors by emulation of WNT3a (using inhibitor
of GSK3b) and IFNg (data not shown).
To exclude the influence of immortalization, we verified
our observations using primary human BMSCs. As ex-
pected, human BMSCs could differentiate to osteogenic
lineage, with or without adding WNT3a, WNT5a, SHH,
PTHrP, BMP-2, and IFNg. Yet their capacity for adipogenesis
was strongly inhibited byWNT3a and IFNg in dose-depen-
dent manner (Figures S3A and S3B). Next, we established
clones initiated by CFU-Fs and identified bipotent ‘‘OA’’
and unipotent ‘‘O’’ and ‘‘A’’ clones, confirming heterogene-
ity of stromal cells in humanbonemarrow.We showed that
‘‘A’’ clones could mineralize in the presence of IFNg, which
also blocked adipogenesis in those cells (Figure S3C).
(legend on next page)
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Together, these data revealed that specific signals can
induce mineralization of adipogenic progenitors at least
in vitro, and thus potentially can dictate osteogenic fate of
skeletal progenitors. Since canonical Wnt and IFNg path-
ways exhibited dual effects, we ranked them as primary
candidates in regulating osteogenic and adipogenic
commitment. Furthermore, we decided to focus on the
IFNg pathway as it is less studied for its effects on lineage
commitment of BMSCs and may reveal novel regulators
of their cell fate.
EGR1 and EGR2 Control Identity of Osteo- and
Adipogenic Skeletal Progenitors
To reveal themechanism controlling osteogenic versus adi-
pogenic commitment of skeletal progenitors, we per-
formed expression profiling by RNA-seq of ‘‘O’’ and ‘‘A’’
progenitors, and the same ‘‘A’’ clones treated with IFNg
for 3 days (Figures 5A and 5B). IFNg treatment of ‘‘A’’ cells
resulted in upregulation of 626 genes and downregulation
of 302 genes (p < 0.05, fold change >2). ‘‘O’’ clones had
higher expression of 607 genes and lower levels of 1,153
genes comparedwith ‘‘A’’ cells.We identified 32 genes char-
acteristic of ‘‘O’’ clones that could be induced in ‘‘A’’ cells by
IFNg (Figure 5C, upper panel), however we did not identify
transcription factors among them. Next we looked at the
converse datasets, and found 59 genes thatwere downregu-
lated in ‘‘O’’ clones and inhibited by IFNg in the ‘‘A’’ cells
(Figure 5C, lower panel), including seven transcription fac-
tors. Remarkably, four of them belonged to the group of
early response genes (Egr1, Fos, Egr2, Fosb). Egr1was among
the top DEGs; therefore, we chose EGR1 and closely related
EGR2 transcription factors for further analysis (Figure 5D).
We confirmed that Egr1 and Egr2 were reproducibly
downregulated in ‘‘A’’ cells in the presence of IFNg in inde-
pendent experiments (Figures S4A and S4B).We performed
reporter assays using luciferase gene placed under control
of 3-kb upstream sequences of Egr1 and Egr2 genes. Lucif-
erase signal was reduced in the presence of IFNg in a
dose-dependent manner (Figures S4C and S4D), which
confirmed that downregulation of both genes occurred at
the transcriptional level. Furthermore, we found enrich-
ment of EGR1 and EGR2 in the promoters of genes for
proteins involved in osteogenic and adipogenic differenti-
ation, such as Sp7, Dlx3, Dlx5, Pparg, Cebpa, Fabp4, andFigure 3. Validation of Differentially Expressed Markers in Skele
(A) Clonal progenitors (O, OA, and A) were checked for co-localizatio
bodies against SP7 (FITC, green) and PPARg (TRITC, red). Insets sho
(B) Expression of DEGs characteristic for adipogenic lineage was valida
(C) Expression of DEGs in BMSC clones with distinct potential from
sequentially on the same membrane, as well as STAT1 and SP7. Loadin
C/EBPa, the positive controls were 293 cells overexpressing correspo
membrane; much lower exposure was needed to visualize control lane
218 Stem Cell Reports j Vol. 11 j 212–227 j July 10, 2018Plin4, using chromatin immunoprecipitation (ChIP) assays
(Figure 6A), suggesting that EGR1 and EGR2 can poten-
tially regulate transcriptional programs and differentiation
potency in skeletal progenitors.
To test the role of EGR1 and EGR2 in regulation of differ-
entiation potency in skeletal progenitors, we performed
genetic knockdown in ‘‘A’’ progenitors using retroviral
transduction (Figure 6B). Knockdown of Egr1 did not affect
levels of osteogenic markers, such as Alpl, Sp7, Dlx3, and
Dlx5, whereas adipogenic genes were significantly downre-
gulated (Pparg 10-fold, Cebpa 5-fold to undetectable
level, Plin4 10- to 20-fold, Fabp42-fold to undetectable)
(Figure 6C). On the other hand, Egr2 knockdown greatly
upregulated osteogenic signature genes (Alpl 6- to 10-
fold, Sp7 10-fold, Dlx3 3- to 5-fold, Dlx5 1.5- to
2.5-fold), while the genes associated with the adipogenic
signature were not markedly changed.
Furthermore, downregulation of Egr1 inhibited the adi-
pogenic capacity of ‘‘A’’ cells (Figure 6D). The cells with
Egr2 knockdown gained osteogenic capacity and showed
elevated level of alkaline phosphatase (AP), which is indic-
ative of osteogenic propensity and could not produce
adipocytes in differentiation conditions. The results of
knockdown experiments were reproduced in two indepen-
dent experiments and using three ‘‘A’’ clones.
Taken together, our data suggest that EGR1 is required for
expression of the adipogenic genes, whereas downregula-
tion of EGR2 can reactivate the osteogenic transcriptional
program in adipogenic cells. Furthermore, reduction of
EGR2 level is sufficient to confer osteogenic properties to
adipogenic progenitors. Thus, EGR1 and EGR2 control
lineage-specific gene expression and identity of skeletal
progenitors.DISCUSSION
Heterogeneity of BMSCs
Skeletal stem cells (also referred to as mesenchymal stem
cells) residing in bone marrow stroma are postulated to
serve as common precursors for cartilage, bone, hemato-
poiesis-supportive stroma, and marrow adipocytes. This
broad spectrum of lineages generated by skeletal stem cells
has been suggested from developmental relations betweental Progenitors
n of osteogenic and adipogenic markers by co-staining with anti-
w corresponding controls stained with only secondary antibodies.
ted by immunostaining in progenitors with O, OA, and A properties.
3 mice shown by western blot. PPARg and C/EBPa were probed
g was confirmed by Ponceau S staining of the blot. For PPARg and
nding proteins (controls and samples for C/EBPa were on the same
).
Figure 4. IFNg and Canonical Wnt Signaling Pathways Stimulate Osteogenic and Inhibit Adipogenic Differentiation of Skeletal
Progenitors
(A) Enrichment of osteo- and adipogenic transcriptional signatures for members of signaling pathways according to the RNA profiling.
(B) A set of signaling molecules was tested for the effect on the osteogenic and adipogenic induction of the ‘‘O’’ (top) and ‘‘A’’ (bottom)
mouse BMSC clones.
(C) Dose dependence of the effect of signaling molecules on the differentiation properties of mouse clonal skeletal progenitors. Osteo-
genesis was quantified by elution of Alizarin Red dye and measurement of OD490, and adipogenesis was assessed by counting the proportion
of adipocytes.
See also Figure S3.those lineages, numerous in vitro differentiation studies
(Morikawa et al., 2009; Peister et al., 2004; Pittenger et al.,
1999), and analysis of heterotopic transplants of BMSC
populations (Friedenstein et al., 1987) isolated from adult
bone marrow. Despite this model being widely accepted,
so far to our knowledge the existence of a single progenitor
contributing to bone, adipocytes, and chondrocytes has
not been shown in vivo in adult mice by stringent assays
such as lineage tracing or single-cell engraftment. There-fore, the questions still remain: which lineages are gener-
ated by skeletal stem cells and what factors control identity
of committed progenitors?
We sought to identify which types of skeletal progenitors
can be isolated from bone marrow of adult mice and how
their differentiation potential can be controlled. Heteroge-
neity of BMSCs in vitro has been examined in previous
studies, which described different combinations of distinct
progenitor types (Banfi et al., 2000; Muraglia et al., 2000;Stem Cell Reports j Vol. 11 j 212–227 j July 10, 2018 219
Figure 5. Gene Expression in ‘‘A’’ Progenitors Treated with IFNg
(A) Expression of genes was analyzed in ‘‘O’’ clones (O4, O5, O6), ‘‘A’’ clones (A4, A5, and A6), and the same ‘‘A’’ clones treated with IFNg for
3 days by RNA-seq. Heatmap of sample correlations based on Euclidean distances; dark blue corresponds to higher similarity.
(legend continued on next page)
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Okamoto et al., 2002; Russell et al., 2010; Sarugaser et al.,
2009; Zhou et al., 2014). Subtypes of skeletal progenitors
with distinct differentiation properties have been also iso-
lated directly from skeletal tissues (Chan et al., 2013,
2015), including multipotent cells capable of generating
bone, cartilage, and stroma in transplantation tests, as
well as restricted bone progenitors and cartilage precursors.
Nevertheless, most experiments in these works were not
performed at a clonal level and the cells were isolated
from fetal or neonatal tissues. In addition chondrogenic
precursors were predominantly found in ear cartilage.
Therefore these results are difficult to align with our clonal
subpopulations of skeletal progenitors from adult bone
marrow.
We found clonal progenitors with all possible seven types
of differentiation potential (‘‘OAC’’, ‘‘OA’’, ‘‘OC’’, ‘‘AC’’,
‘‘O’’, ‘‘A’’ and ‘‘C’’) according to in vitro differentiation as-
says, making it plausible to suggest that osteogenic, adipo-
genic, and chondrogenic differentiation properties can be
independently combined in the clones. Our expression
profiling results were consistent with this model; we iden-
tified specific transcriptional programs correlating with
osteogenic and adipogenic commitment, and clones with
both properties shared expression of these programs and
did not show exclusive genes.
Given the findings of transcriptome analysis, we suggest
that osteogenic and adipogenic signatures are notmutually
exclusive and that specific types of skeletal progenitors co-
express alternative lineage-specific genes. This observation
contrasts with the classical view of differentiation, which is
based on progression through a hierarchical system of in-
termediate states with specific identity. Nonetheless, the
phenomenon of shared transcriptional programs has
been proposed as ‘‘lineage priming’’ for different systems,
including hematopoietic stem cells (Hu et al., 1997; Lau-
renti et al., 2013; Ng et al., 2009) and inner cell mass of
blastocyst (Guo et al., 2010; Plusa et al., 2008). These lines
of evidence suggest that activation of multiple transcrip-
tional lineage-specific signatures can be a commonmecha-
nism of early commitment of progenitors in different
biological systems.
An additional question arising from our results is why
the transcriptional signature for the chondrogenic lineage
could not be identified from our expression profiling. We
did not perform RNA-seq of ‘‘C’’ clones due to their rarity,
and this may be the reason why this signature was not
prominent in bioinformatics analysis. Yet it has been
recently shown that in vitro chondrogenic differentiation(B) Upregulation of known IFNg-regulated genes in the clones with
(C) Analysis of RNA-seq results for differential expression of genes
enrichment of GO terms and checked for the presence of transcriptio
(D) Comparison of Egr1 and Egr2 expression in clones analyzed by RNof BMSCs can be reverted back to the undifferentiated
state both in vitro in culture conditions for BMSCs and
in vivo after transplantation, and thus does not represent
stable commitment to chondrogenic lineage (Serafini
et al., 2014). Taking into account that postnatal BMSCs
have not been rigorously shown to form cartilage using
in vivo tests such as transplantations or lineage tracing,
whether bone marrow skeletal progenitors possess bona
fide intrinsic chondrogenic potency still remains to be
proved.
The other question is whether it is possible to predict
the relationships between different subpopulations of
progenitors. We performed rigorous assessment of their
osteogenic potential by transplantation with HA/TCP
scaffolds (Kuznetsov et al., 1997; Sacchetti et al., 2007,
2016). Despite the limited number and variety of clones
assayed, our results revealed that the osteogenic clones
lacking adipogenic potency (‘‘OC’’) could generate bone
ossicle upon transplantation, whereas all clones with adi-
pogenic properties in vitro (such as ‘‘A’’ and ‘‘OAC’’) could
not. One possible explanation for multipotent cells
(‘‘OAC’’) not being able to generate bone in vivo could be
that these cells might require additional inductive signals
from the environment to commit to osteogenic lineage,
which could be present in the bone but were absent at het-
erotopic site of transplantation. On the other hand, these
results challenge the view that clones showing multipo-
tency in vitro can generate both adipo- and osteogenic
lineages and are upstream of progenitors restricted to
osteogenesis. It is also conceivable, although highly
speculative, that osteogenic progenitors (‘‘O’’) progress to-
ward non-osteogenic state (‘‘A’’), whereas the clones
combining osteogenic and adipogenic properties (‘‘OA’’)
represent a transitory population between those two
cell types. In this case, combined expression of two signa-
tures may reflect the process of ‘‘swapping’’ the programs
and ‘‘OA’’ clones remain responsive to osteogenic cues
in vitro, having in fact lost this potency in an in vivo
context. This is a theoretical assumption that needs to
be further explored.
Mechanisms Controlling Lineage Commitment
Mechanisms regulating the process of differentiation in
adult tissues have been intensively investigated using
transgenic mice and in vitro cell culture systems. In
contrast, knowledge of factors controlling identity of un-
differentiated stem and progenitor cells is still scarce,
mainly due to the inability to isolate and propagate pure‘‘A’’ properties upon treatment with IFNg.
(p < 0.05). The lists of overlapping DEGs were characterized for
n factors.
A-seq for three independent clones.
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populations of these cells. We characterized undifferenti-
ated cells committed to different lineages and proposed
IFNg and WNT3a as candidates to control osteogenic and
adipogenic fate.
Canonical Wnt was suggested to stimulate osteogenesis
based on the phenotype in bones and BMSCs of patients
with loss-of-function and gain-of-function mutations in
Wnt co-receptor LRP5 (Gong et al., 2001; Qiu et al.,
2007). Further experiments confirmed that canonical
Wnt signaling stimulates osteogenesis while inhibiting adi-
pogenic differentiation in cultured BMSCs (Taipaleenma¨ki
et al., 2011) and in mice (Bennett et al., 2005), which is in
accord with our results.
The role of IFNg in differentiation of skeletal progeni-
tors is less understood, partly because IFNg can promote
osteoclast differentiation (Xiong et al., 2016), which
makes it complicated to analyze the autonomous effect
of IFNg on skeletal progenitors in model organisms.
Nevertheless, IFNg was shown to enhance osteogenesis
and inhibit adipogenesis in BMSCs in vitro and in mice af-
ter injection (Duque et al., 2009; Vidal et al., 2012). More-
over, knockout mice for IFNgR1 receptor show impaired
osteogenesis (Duque et al., 2011), which implies a physi-
ological role of IFNg in differentiation of skeletal cell
types. The common sources of IFNg production are
T cells, natural killer cells, and macrophages (Schoenborn
and Wilson, 2007). Furthermore, BMSCs may produce
IFNg in autocrine fashion (Duque et al., 2009), although
we did not detect its expression, at least in our experi-
mental system. Therefore, in the bone marrow context,
IFNg signal may arise from interaction of skeletal progen-
itors with a hematopoietic compartment, or by being
stimulated as an autocrine signal in response to other
factors.
Expression of IFNg targets without exogenous IFNg in
undifferentiated adipogenic clones is an interesting phe-
nomenon, although the level of their expression was
much lower than in the presence of ligand. A recent workFigure 6. EGR1 and EGR2 Control Identity of Skeletal Progenitors
(A) Presence of EGR1 and EGR2 at putative binding sites in the promote
by ChIP-qPCR in ‘‘A’’ clone. Percentage from input for mock was in most
of chromosome 9 and Cebpa promoter distant from binding sites (sho
indicate the SD of technical replicates of qPCR reactions.
(B) Genetic knockdown of Egr1 and Egr2 was done using two inde
expression was tested by qRT-PCR relative to the scrambled control. E
(C) Gene expression analysis in the cells with Egr1 and Egr2 knockdo
indicate the SD of technical replicates of qPCR reactions.
(D) The cells with Egr1 and Egr2 knockdowns were tested for AP exp
entiation (Oil Red O staining). Quantification: AP by counting propo
osteogenesis by elution of bound Alizarin Red and measurement of OD
indicate the SD of technical replicates.
See also Figure S4.by Wu et al. (2018) showed that undifferentiated pluripo-
tent and tissue-specific stem cells exhibited intrinsic
expression of interferon-stimulated genes (ISG) without
IFNg in the environment, and were resistant to viral infec-
tion. ISGs were downregulated during differentiation and
concomitantly the cells became sensitive to viral infection.
Similarly to our study, the event that induced this endoge-
nous ISG program remained unknown. We also observed
downregulation of IFNg targets during differentiation of
BMSCs (result not shown); it would be interesting to next
test whether our skeletal progenitors are sensitive to viral
infection.
Furthermore, our observations are congruent with the
previous report that a subset of BMSCs labeled by Mx1-
Cre induction is a stress-responsive osteogenic stem/
progenitor cell population lacking detectable adipogenic
capacity (Park et al., 2012). pIpC used for induction of
Mx1-Cre labeling is a synthetic analog of double-stranded
RNA, which induces IFNg response in cells, including
Mx1. Thus, it is possible that properties ofMx1-labeled pro-
genitors reflect a stimulatory effect of IFNg on osteogenic
potency and suppression of adipogenic capacity that we
describe. More experimental evidence, including lineage
tracing and in vivo tracking, is required to reveal whether
IFNg-mediated modulation of cell fate specification occurs
in homeostasis or regeneration.
Our transcriptome analysis and functional data from
short hairpin RNA (shRNA) knockdown suggested that
transcription factor EGR1 is required for expression of adi-
pogenic regulators and adipogenesis in ‘‘A’’ cells, whereas
EGR2 suppressed pro-osteogenic genes and osteogenic
properties in ‘‘A’’ cells. Egr2 knockdown also inhibited adi-
pogenesis, indicating that EGR2 may be essential or that
elevation of osteogenic regulators suppressed adipogenesis.
Nevertheless, both EGR1 and EGR2 contributed to
control of expression of lineage signatures in skeletal
progenitors. As we found both proteins to be present in
the promoters of major regulators of osteogenesis andr regions of known osteogenic and adipogenic regulators was tested
cases negligible; the signal in the control region in intergenic space
wn in red) was very low compared to the putative sites. Error bars
pendent shRNA-encoding constructs for each gene in ‘‘A’’ clone;
rror bars indicate the SD of technical replicates of qPCR reactions.
wn as shown by qRT-PCR relative to scrambled control. Error bars
ression, osteogenic (Alizarin Red staining), and adipogenic differ-
rtion of stained cells (total number of counted cells is indicated),
490, adipogenesis by counting proportion of adipocytes. Error bars
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adipogenesis (such as Sp7, Dlx3, Dlx5, Pparg, Cebpa), the
effect on these genes can be direct. There was no major dif-
ference in EGR1 and EGR2 distribution, which is perhaps
not surprising considering high similarity in their DNA
binding domain (Swirnoff and Milbrandt, 1995). Thus
their distinct effects can be explained by recruitment of
different interactors, which can mediate transcription acti-
vation or repression.
In concordance with our results, EGR1 and EGR2 have
been shown to play a role in differentiation of skeletal tis-
sues in vivo. Egr1 knockout mice display normal osteoblas-
togenesis (Cenci et al., 2000; Reumann et al., 2011) but
increased resistance to adiposity induced by a high-fat
diet (Zhang et al., 2013). On the other hand, bone marrow
of Egr2+/ mice contained almost 2-fold more osteogenic
colony-forming units compared with the wild-type litter-
mates, indicating increased osteogenic properties of BMSCs
(Gabet et al., 2010). Together, these data indicate that EGR1
is a positive regulator of adipogenic differentiation, while
EGR2 is a suppressor of osteogenesis in the skeletal progen-
itors in vivo.
In conclusion, we present here comprehensive character-
ization of transcriptome of distinct types of skeletal
progenitors, which we believe will facilitate further investi-
gations, including studies of their differentiation and
origin. Furthermore, we found that in skeletal progenitors
EGR2 suppresses osteogenic transcriptional program and
differentiation propensity, whereas EGR1 maintains
expression of adipogenic genes and ability to differentiate.
Although many questions about the identity of skeletal
progenitors remain to be answered by future studies, here
we provide a previously unknown mechanism of their
cell fate control.EXPERIMENTAL PROCEDURES
BMSC Isolation and Culture
BMSCs were isolated by flushing the femora and tibiae of irtTA-
GBD*-TAg transgenic mice. Cell expansion and differentiation
were performed as described previously (Rostovskaya and Anastas-
siadis, 2012) and in Supplemental Experimental Procedures.
Transplantation Assays
The animal experiments were done under appropriate approval;
the number of the authorization released by the Italian Ministry
of Health is 1282/2015. 23 106 cells were loaded onto hydroxyap-
atite/tricalcium phosphate (HA/TCP) particles (40 mg, 100–
200 mm; Zimmer, Warsaw, IN), then subcutaneously transplanted
into the backs of 6- to 15-week–old female SCID/beige mice and
analyzed after 8 weeks.
Library Preparation and Sequencing
Isolation of mRNA was done using bead-based poly(dT) selection
followed by chemical fragmentation and further processing for224 Stem Cell Reports j Vol. 11 j 212–227 j July 10, 2018Illumina short-read sequencing (HiSeq 2000). For strand-specific
sequencing, two different versions of the dUTPmethod (Parkhom-
chuk et al., 2009) were applied (for details see Supplemental Exper-
imental Procedures).Chromatin Immunoprecipitation
Protein-DNA complexes were crosslinked with 2 mM disuccini-
midyl glutarate and 1% formaldehyde followed by sonication.
DNA was precipitated with EGR1 or EGR2 antibody and protein
G Sepharose beads, purified, and used for qPCR.shRNA Knockdown
The gene knockdowns were done via retroviral transduction of
shRNA-encoding vectors pLKO.1-puro listed in Supplemental
Experimental Procedures.ACCESSION NUMBERS
The RNA-seq data in this paper have been deposited in NCBI’s
Gene Expression Omnibus under series accession numbers GEO:
GSE114474 and GSE114475.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article
online at https://doi.org/10.1016/j.stemcr.2018.05.014.
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